CDMO logo

Avid Bioservices, Inc. Stock Price

NasdaqCM:CDMO Community·US$798.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

CDMO Share Price Performance

US$12.49
0.03 (0.24%)
US$12.49
0.03 (0.24%)
Price US$12.49

CDMO Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Slightly overvalued with limited growth.

2 Risks
1 Reward

Avid Bioservices, Inc. Key Details

US$150.4m

Revenue

US$138.9m

Cost of Revenue

US$11.6m

Gross Profit

US$163.6m

Other Expenses

-US$152.0m

Earnings

Last Reported Earnings
Oct 31, 2024
Next Reporting Earnings
n/a
-2.38
7.68%
-101.07%
344.0%
View Full Analysis

About CDMO

Founded
1981
Employees
371
CEO
Nicholas Green
WebsiteView website
www.avidbio.com

Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.

Recent CDMO News & Updates

Recent updates

No updates